Log in
ETR:GXI

Gerresheimer Stock Forecast, Price & News

€95.55
+1.25 (+1.33 %)
(As of 09/28/2020 12:00 AM ET)
Add
Compare
Today's Range
€94.60
Now: €95.55
€95.75
50-Day Range
€93.60
MA: €96.56
€100.10
52-Week Range
€50.65
Now: €95.55
€101.10
Volume70,208 shs
Average Volume140,925 shs
Market Capitalization$3.00 billion
P/E RatioN/A
Dividend Yield1.25%
BetaN/A
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for medicines and cosmetics, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and care and decorative cosmetics; and bottles and jars for spirits and food. The Advanced Technologies division develops drug delivery products and platforms, such as micro pumps, which are used to self-administer medication for diabetes or Parkinson's for pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.
Read More
Gerresheimer logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.1Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.90 out of 5 stars


Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-211-618100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.39 billion
Cash Flow€3.47 per share
Book Value€29.20 per share

Profitability

Miscellaneous

Employees9,867
Market Cap$3.00 billion
Next Earnings Date10/13/2020 (Estimated)
OptionableNot Optionable
€95.55
+1.25 (+1.33 %)
(As of 09/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GXI News and Ratings via Email

Sign-up to receive the latest news and ratings for GXI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Gerresheimer (ETR:GXI) Frequently Asked Questions

How has Gerresheimer's stock been impacted by COVID-19 (Coronavirus)?

Gerresheimer's stock was trading at €59.55 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GXI stock has increased by 60.5% and is now trading at €95.55.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Gerresheimer?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Gerresheimer in the last year. There are currently 3 sell ratings, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Gerresheimer
.

When is Gerresheimer's next earnings date?

Gerresheimer is scheduled to release its next quarterly earnings announcement on Tuesday, October 13th 2020.
View our earnings forecast for Gerresheimer
.

What price target have analysts set for GXI?

9 analysts have issued 12-month price targets for Gerresheimer's shares. Their forecasts range from €50.00 to €115.00. On average, they expect Gerresheimer's stock price to reach €89.09 in the next twelve months. This suggests that the stock has a possible downside of 6.8%.
View analysts' price targets for Gerresheimer
.

Who are some of Gerresheimer's key competitors?

What other stocks do shareholders of Gerresheimer own?

Who are Gerresheimer's key executives?

Gerresheimer's management team includes the following people:
  • Mr. Dietmar Siemssen, CEO & Member of Management Board (Age 56)
  • Dr. Lukas Burkhardt, Member of Management Board (Age 40)
  • Ms. Katja Schnitzler, Group Director of Bus. Excellence & Continuous Improvement and Member of the Supervisory Board (Age 38)
  • Ms. Severine Camp, Corp. Sr. Director of Investor Relations
  • Mr. Jens Kürten, Group Sr. Director of Communication & Marketing and Press Officer of Corp. Media

What is Gerresheimer's stock symbol?

Gerresheimer trades on the ETR under the ticker symbol "GXI."

What is Gerresheimer's stock price today?

One share of GXI stock can currently be purchased for approximately €95.55.

How big of a company is Gerresheimer?

Gerresheimer has a market capitalization of $3.00 billion and generates $1.39 billion in revenue each year. Gerresheimer employs 9,867 workers across the globe.

What is Gerresheimer's official website?

The official website for Gerresheimer is www.gerresheimer.com.

How can I contact Gerresheimer?

Gerresheimer's mailing address is Klaus-Bungert-Strasse 4, DUESSELDORF, 40468, Germany. The company can be reached via phone at +49-211-618100.

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.